Significance of inflammatory markers in diabetic patients with stable coronary artery disease
- PMID: 19721857
- PMCID: PMC2732780
- DOI: 10.3904/kjim.2009.24.3.212
Significance of inflammatory markers in diabetic patients with stable coronary artery disease
Abstract
Background/aims: Patients with diabetes are prone to coronary artery disease (CAD); however, the majority of diabetic patients show normal coronary arteries. We examined differences in the clinical aspects of diabetic patients with insignificant and with significant stenosis of the coronary artery.
Methods: A total of 418 consecutive diabetic patients with stable angina who had undergone coronary angiography from January 2004 to March 2007 were included in this study. Patients were subdivided into control and CAD groups and then clinical characteristics and CAD-associated factors were evaluated.
Results: A total of 92 (22%) patients were assigned to the control group and 326 (78%) patients were assigned to the CAD group. Using univariate regression analysis, we found that patients with CAD were significantly older (control vs. CAD; 59+/-21 vs. 64.7+/-33.7, years, p<0.001), had a longer duration of diabetes (8.2+/-21.8 vs. 10.2+/-29.8, years, p=0.027), higher titers of high sensitivity C-reactive protein (hsCRP; 0.3+/-6.79 vs. 0.9+/-12.6, mg/dL, p=0.015), and increased hemoglobin A1c (HbA1c) levels (7.1+/-3.8 vs. 7.5+/-4.8, %, p=0.007) compared to control patients. Multivariate regression analysis showed that only differences in age, hsCRP, and HbA1c were statistically significant. When patients were subdivided into groups based on hsCRP levels (208 patients in the low group [49.8%], 210 patients in the high group [50.2%]), we found that patients with higher hsCRP levels showed more frequent multivessel disease.
Conclusions: In diabetic patients, age, hsCRP, and HbA1c were associated with stable CAD. Among these factors, hsCRP levels were significantly correlated with multivessel involvement in diabetic CAD. Therefore, high hsCRP levels may be a strong predictor for atherosclerotic progression of the coronary arteries in diabetic patients, suggesting that regular screening tests should be performed.
Keywords: C-reactive protein; Coronary artery disease, stable; Diabetes mellitus.
Figures
Similar articles
-
Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.Clin Biochem. 2007 Jul;40(11):810-6. doi: 10.1016/j.clinbiochem.2007.03.022. Epub 2007 Apr 19. Clin Biochem. 2007. PMID: 17499233
-
Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity.Diabetes Res Clin Pract. 2013 Dec;102(3):225-32. doi: 10.1016/j.diabres.2013.10.011. Epub 2013 Oct 9. Diabetes Res Clin Pract. 2013. PMID: 24176244
-
Plasma interleukin-27 levels in patients with coronary artery disease.Medicine (Baltimore). 2017 Oct;96(43):e8260. doi: 10.1097/MD.0000000000008260. Medicine (Baltimore). 2017. PMID: 29068992 Free PMC article.
-
The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease.Clin Biochem. 2021 Jul;93:50-58. doi: 10.1016/j.clinbiochem.2021.04.004. Epub 2021 Apr 13. Clin Biochem. 2021. PMID: 33861985
-
Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):3-6. J Ayub Med Coll Abbottabad. 2008. PMID: 19385446
References
-
- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431. - PubMed
-
- Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001;24:1936–1940. - PubMed
-
- Wingard DL, Barrer-Connor E National Diabetes Data Group, editors. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995. Heart disease and diabetes; pp. 429–448.
-
- Grundy SM, Howard B, Smith S, Jr, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002;105:2231–2239. - PubMed
-
- Butler WJ, Ostrander LD, Jr, Carman WJ, Lamphiear DE. Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol. 1985;121:541–547. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous